The global market for Behçet's disease therapeutics is witnessing a period of significant growth, driven by an increasing prevalence of the disease and advancements in treatment options. The need for effective therapies to manage the diverse symptoms of Behçet's disease is fueling this expansion. Pharmaceutical companies are actively investigatin